Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing <i>in vivo</i>
Anne Rensing‐Ehl(University Medical Center Freiburg), A. Fontana(Astronomical Observatory of Rome), Karl Frei(University of California, Riverside), Bernd Matiba(German Cancer Research Center), Sara M Mariani(German Cancer Research Center), Peter H. Krammer(Slovak Academy of Sciences), Patrick Aebischer(École Polytechnique Fédérale de Lausanne), Renata Flury(University of Zurich), Michael Weller(University Hospital of Zurich)
Cited by 197
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k